Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis - Wikidata - wikimedia - TriplyDB

Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis

Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis

http://www.wikidata.org/entity/Q34535040

about

Optimizing treatments for lymphangioleiomyomatosis Lymphangioleiomyomatosis: differential diagnosis and optimal management Management of lymphangioleiomyomatosis Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis Sub-micrometer-precision, three-dimensional (3D) hydrodynamic focusing via "microfluidic drifting".Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness An integrated, multiparametric flow cytometry chip using "microfluidic drifting" based three-dimensional hydrodynamic focusing.Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM)Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm Lymphatic endothelial differentiation in pulmonary lymphangioleiomyomatosis cells.Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis.Update in diffuse parenchymal lung disease 2010.A survey of state-of-the-art surface chemistries to minimize fouling from human and animal biofluids.New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex.Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis.Exonic mutations of TSC2/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis.Genetic heterogeneity of circulating cells from patients with lymphangioleiomyomatosis with and without lung transplantation.Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancer.Cystic Lung Disease in Genetic Syndromes with Deficient Tumor Suppressor Gene Function.Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.Emerging biomarkers of lymphangioleiomyomatosis.The LAM Lung Cell and Its Human Cell Models.Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.Alterations of the mTOR pathway in hepatic angiomyolipoma with emphasis on the epithelioid variant and loss of heterogeneity of TSC1/TSC2.Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration

P2860

Q26865250-1CD46E83-BF05-4340-AF92-C9072D2682F1 Q27022412-1DB5458B-C089-4A16-AA9E-84784D23F54B Q28084725-8C192458-CE2D-4DE9-9474-6E69791F7898 Q28084975-AD503739-90E2-46BB-83FB-5C7501C96181 Q30576307-F879543B-FE2D-49D2-9D52-EFF99F23C28C Q34560457-A42297D4-35B1-4387-90BA-09E71C1DF7E9 Q35689467-ABE0BF55-D77A-4E62-A00B-AF29C7B9711D Q35935341-7D47838B-C6C7-4DAC-B88D-19E715A10996 Q36095750-3B2448C9-91BD-4828-B580-DEAFDDFCD198 Q36636671-1577117C-0182-46D2-B0DC-DBB2285189A7 Q36755080-5F5D2785-E692-469D-9E4A-8D8D27600A3A Q37047634-9D4EB133-E05A-48AF-90FD-2E2966E7D504 Q37149062-02628184-F82E-4B0C-BA65-BF5F50B86860 Q37397803-C9582FA7-2A5C-410C-89B0-BDE4BCE175FA Q37443410-E9ADA5D3-EC05-4664-8255-9570627DAFDD Q37877430-5EBD32F6-15DF-4CA6-A863-484462E00CA6 Q38555389-02B0938D-81C9-465F-8127-B704F89706FA Q38983786-BD747206-B786-4F4E-BC51-ABDB8FA9DEFF Q40740177-B4997143-0F7A-464B-9D4D-8475DD27E244 Q42537376-8BB27C3E-C093-44E7-BE32-330ED89C39A3 Q42592422-7AC675F1-0031-47B4-BD98-A03922834719 Q43178519-38EE3426-6E44-43B8-A2CB-CAB4946CE008 Q47370738-631CC166-105C-46EF-A421-91F342440464 Q48355779-936B7C25-1A76-44BB-B840-CAA3A0EA4FAA Q49679457-45462E8C-5494-4EF2-8F89-2DF7BAAF664F Q50181460-8DCBD57C-3A70-40D2-B5FE-CC1EBC3B5A68 Q51474084-A09316CC-0B7E-4A11-AE57-F27292A9D32B Q51779283-05A39B0A-E9D2-4A5A-B582-295FB21D96FE Q54321126-DA565F8D-F223-4258-BDF6-85A1D2367387 Q57050448-9164792E-855D-4738-9AD1-ABDCBE21AD04

P2860

Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis

http://www.wikidata.org/entity/Q34535040

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Phenotypic characterization of ...... with lymphangioleiomyomatosis

@ast

Phenotypic characterization of ...... with lymphangioleiomyomatosis

@en

Phenotypic characterization of ...... with lymphangioleiomyomatosis

@nl

type

label

Phenotypic characterization of ...... with lymphangioleiomyomatosis

@ast

Phenotypic characterization of ...... with lymphangioleiomyomatosis

@en

Phenotypic characterization of ...... with lymphangioleiomyomatosis

@nl

prefLabel

Phenotypic characterization of ...... with lymphangioleiomyomatosis

@ast

Phenotypic characterization of ...... with lymphangioleiomyomatosis

@en

Phenotypic characterization of ...... with lymphangioleiomyomatosis

@nl

P1433

Q34535040-79C7BBBB-0C80-4671-9584-7BA5E63613F6

P1476

Q34535040-62FC21C9-FFB8-4C46-A262-B780A5482614

P2093

Q34535040-0E7066E3-9FD6-439E-9AB5-B9184A8F9380

Q34535040-13118E4C-E0FD-4BC6-AFC0-CF930C2D60A0

Q34535040-201E2EE1-72B2-4B43-988A-DFB65DE1BB10

Q34535040-3DFBDA56-4D8C-418C-847E-5DD6F9FBB256

Q34535040-5664EA0C-A80E-4AFB-9694-26B94DAFC84B

Q34535040-6275EF42-3BF2-48EB-9D47-7F71C8A87089

Q34535040-6447B637-AF4E-49D9-A8DE-A2A9C7C5AE09

Q34535040-92956081-EA1F-4BD0-965A-670E3A21E793

Q34535040-A6E4A39B-F054-4175-AA3F-9A9124B4EACD

Q34535040-BC659DE9-A001-42C2-9571-187E69B52513

P2860

Q34535040-04D5665B-C782-4BE5-9FE9-EFB0F7C391E5

Q34535040-0E55A10C-E0A7-4B5B-AA3B-D9151B1227D0

Q34535040-1721308D-6A1C-45B7-8E67-0AA0A8CCC0F2

Q34535040-243428A9-994E-4233-86B3-641EF6D890AE

Q34535040-332CB993-5BAB-41C5-AF6D-8B6C06CAD2D7

Q34535040-334201B4-D705-41D2-AFCE-9889113E1B3F

Q34535040-33D54F5B-C4AE-46E0-8D15-E767CD5CB95D

Q34535040-3F7B0993-EC5F-4E2D-B75C-E0E4894A0097

Q34535040-47DB43A8-EA60-406A-9555-202E03E82B8D

Q34535040-5CBE8B68-F92C-44C6-B282-037EC11CB79F

P304

Q34535040-6DA57C61-40B6-430F-AD3A-A37236AF46B3

P31

Q34535040-1AB86F74-18F4-424A-A0A6-9E54D4E04AA5

P356

Q34535040-7F5ECC81-FD80-4405-8AE1-27121CFB9512

P407

Q34535040-ADED4B3F-9601-4DD5-82A2-F323FAC7F946

P433

Q34535040-75166747-A82E-453A-B234-6C78ADD50927

P478

Q34535040-001C8541-8DF8-42A0-AD0A-90C28912B9D7

P50

Q34535040-88BF45E1-5195-487E-BEC9-57EB7FA6ECEE

P577

Q34535040-A484D361-E6A3-4F45-AFE9-3E22BD74D615

P698

Q34535040-FE646D95-72CE-429C-A7F5-6BFE7194A084

P921

Q34535040-FB698AD8-8066-47EC-BA9A-FD756F6D79F1

P932

Q34535040-78DA1BBE-B60D-4009-B473-03723AF9F769

P356

RCCM.201003-0489OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Phenotypic characterization of ...... with lymphangioleiomyomatosis

@en

P2093

Gustavo Pacheco-Rodriguez

http://www.w3.org/2001/XMLSchema#string

Hai-Ping Wu

http://www.w3.org/2001/XMLSchema#string

J Philip McCoy

http://www.w3.org/2001/XMLSchema#string

Jing-Ping Lin

http://www.w3.org/2001/XMLSchema#string

Joel Moss

http://www.w3.org/2001/XMLSchema#string

Leigh Samsel

http://www.w3.org/2001/XMLSchema#string

Mary Haughey

http://www.w3.org/2001/XMLSchema#string

Qing-Yuan Fan

http://www.w3.org/2001/XMLSchema#string

Souheil El-Chemaly

http://www.w3.org/2001/XMLSchema#string

Wendy K Steagall

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas

CD44: from adhesion molecules to signalling regulators

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

Identification and characterization of the tuberous sclerosis gene on chromosome 16

Tetraspanin functions and associated microdomains

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

Cancer metastasis: building a framework

The tetraspanin superfamily: molecular facilitators.

Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex.

P304

1410-1418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201003-0489OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P50

Thomas N. Darling

P577

2010-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20639436

http://www.w3.org/2001/XMLSchema#string

P921

P932

3029931

http://www.w3.org/2001/XMLSchema#string